Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-Paclitaxel and Cisplatin in Advanced Biliary Tract Cancers
NCT04111380Phase 2Unknown
- Sponsor
- Henan Provincial People's Hospital
- Start
- Sep 2019
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in biliary tract cancer (BTC), sponsored by Henan Provincial People's Hospital. Primary endpoint: Objective Response Rate at 2 years. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT04111380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04111380.